Skip to main content

Dutch, Indian Companies to Form Nutrigenomics Joint Venture

NEW YORK, Nov. 23 (GenomeWeb News) - Avestha Gengraine Technologies and TNO Quality of Life said plan to form a joint venture as part of their plan to develop genomic-based and plant-derived nutritional products.

Avestha is based in Indiaand TNO is based in the Netherlands. Terms of the alliance call for the companies to combine "traditional" plant-based medicine developed in Indiawith genomic technologies to study metabolic syndrome, diabetes, obesity, and cardiovascular diseases, the companies said.

TNO has developed several human disease models in animals and have a model for kinetic studies in digestive physiology, as well as expertise in nutrigenomics research. Currently, the company is a coordinator of the European Union's Human Nutrigenomics Project.


For its part, Avesthagen will bring to the collaboration its experience in India's traditional medicine, access to bioactive plant extracts, and expertise in plant genetic technologies.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.